A Study on a Novel Biomarker in People with Type 2 Diabetes Who Have Cardiac Autonomic Neuropathy

Article Sidebar

PDF
Published: Jan 11, 2023
Keywords:
Cardiac Autonomic Neuropathy Novel Biomarker Type 2 Diabetes

Main Article Content

K. M. Vaghasiya
Tutor. Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed to Be University”,Karad –415110,Maharashtra
D. V. Sarvaiya
Tutor. Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed to Be University”, Karad –415110, Maharashtra
P. S. Salve
Assistant Professor Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth “Deemed To Be University”,Karad –415110,Maharashtra

Abstract

The purpose of this study is to examine the new biomarker in individuals with type 2 diabetes and cardiac autonomic neuropathy. The research was cross-sectional in nature. From May 2020 to November 2021, 211 patients were involved in this study. The current study's findings corroborate previous research showing that serum NSE levels are dramatically increased in T2DM with CAN. A biomarker with promise and a possible role in the diagnosis of CAN patients is elevated blood NSE levels.

Article Details

How to Cite
Vaghasiya, K. M. ., Sarvaiya, D. V. ., & Salve, P. S. . (2023). A Study on a Novel Biomarker in People with Type 2 Diabetes Who Have Cardiac Autonomic Neuropathy. Journal of Coastal Life Medicine, 11(1), 2834–2842. Retrieved from https://www.jclmm.com/index.php/journal/article/view/764
Issue
Vol. 11: Number 1, 2023
Section
Articles

References

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26: 1553–1579.

Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 6: 1895–1901.

Maser R, Lenhard M, DeCherney G. Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist. 2010; 10: 27–33.

Schumer MP, Joyner SA, Pfeifer MA. Cardiovascular autonomic neuropathy testing in patients with diabetes. Diabet Spectr. 2018; 11: 227–223.

Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, Lowel H. Diminished heart rate variability (HRV) and prolonged QTc interval, but not increased QT dispersion (QTD) are predicators of mortality in the diabetic population. Diabetes. 2004; 53 (suppl 2): A57.

Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, Lowel H. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006; 114: 153–159.

Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2020; 48: 164–171.

Ewing DJ, Clarke BF. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care. 2018; 9: 648–665.

Vinik A, Erbas T, Pfeifer M, Feldman M, Feldman E, Stevens M, Russell J. Diabetic autonomic neuropathy. In: Porte D Jr, Sherwin RS, Baron A, eds. Ellenberg & Rifkin’s Diabetes Mellitus. 6th ed. New York, NY: McGraw-Hill; 2013: 789–804.

Kahn JK, Zola B, Juni JE, Vinik AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol. 2019; 7: 1303–1309.

Vinik A, Erbas T. Neuropathy. In: Ruderman N, Devlin JT, Schneider S, Kriska A, eds. Handbook of Exercise in Diabetes. Alexandria, Va: American Diabetes Association; 2012.

American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2006; 9 (suppl 1): S4–S42.

Colberg S, Swain D, Vinik A. Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care. 2013; 26: 986–990.

Position paper. Orthostatic hypotension, multiple systems atrophy (the Shy Drager Syndrome). J Auton Nerv Syst. 1996; 58: 123–124.

Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus: diagnostic and prognostic value. Circulation. 2016; 113: 583–592.

Burgos LG, Ebert TJ, Asiddao C, Turner LA, Pattison CZ, Wang-Cheng R, Kampine JP. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. 2020; 70: 591–597.

Kitamura A, Hoshino T, Kon T, Ogawa R. Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology. 2012; 92: 1311–1318.

Sobotka PA, Liss HP, Vinik AI. Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab. 2014; 62: 658–663.

Wiggin, TD., Sullivan, KA., Pop-Busui, R., Amato, A., Sima, AA., Feldman, EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009; 58:1634-40.

Lee, KE., Ji, Sun Nam., Chul, Woo Ahn., Ji-Man, Hong., Seung-Min, Kim ., Il-Nam ,Sunwoo.,Joon-Shik, Moon ., Sang-Jun, Na., Young-Chul, Choi. Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients. Acta Diabetol 2012; 49:97–103.

Spallone, V., Ziegler, D., Freeman, R., et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res. 2011; 27:639-653.